Company / Shares Outstanding
Acadia Pharmaceuticals Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
166.7M
FY2025
5-year range
159.6M / 166.7M
FY2021-FY2025
Trend
+1.3%
vs FY2024
Sector context
#54 of 212
Health Care
What the data says
Acadia Pharmaceuticals's shares outstanding of 166708856.00 is higher than 75% of companies in the Health Care sector (FY2025). Shares Outstanding has increased for 9 consecutive years, from 101938702.00 in FY2016 to 166708856.00 in FY2025.
Based on SEC 10-K filings.
166708856.00 in FY2025 with a 5-year CAGR of +1.4%.
Increased from 162064872.00 to 166708856.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +1.2%
- 5-Year CAGR
- +1.4%
- 10-Year CAGR
- -
Sector benchmark
-45.5% below sector average
Key checks
Key Insights
- Acadia Pharmaceuticals's shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 1.3% year-over-year.
- Ranks #54 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 166.7M | +1.3% |
| FY2024 | 164.7M | +1.6% |
| FY2023 | 162.1M | +0.7% |
| FY2022 | 161.0M | +0.9% |
| FY2021 | 159.6M | +2.8% |
| FY2020 | 155.3M | +7.9% |
| FY2019 | 143.9M | +15.6% |
| FY2018 | 124.4M | +2.5% |
| FY2017 | 121.4M | +19.1% |
| FY2016 | 101.9M | +1.9% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026